[Newly described mutations in ERBB2 may play a role in predicting response to epidermal growth factor receptor (EGFR) -targeted therapy in hepatoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE